Affiliations 

  • 1 *Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, South Korea; †The Kirby Institute, UNSW Australia, Sydney, Australia; ‡Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), YRGCARE Medical Centre, VHS, Chennai, India; §Working Group on AIDS Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; ‖Research Institute for Health Sciences, Chiang Mai, Thailand; ¶Queen Elizabeth Hospital, Hong Kong, China; #Hospital Sungai Buloh, Sungai Buloh, Malaysia; **National Center for Global Health and Medicine, Tokyo, Japan; ††Taipei Veterans General Hospital, Taipei, Taiwan; ‡‡University Malaya Medical Centre, Kuala Lumpur, Malaysia; §§Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand; ‖‖HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand; ¶¶Tan Tock Seng Hospital, Singapore; ##Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; ***Beijing Ditan Hospital, Capital Medical University, Beijing, China; †††Institute of Infectious Diseases, Pune, India; ‡‡‡Research Institute for Tropical Medicine, Manila, Philippines; §§§Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand; ‖‖‖Faculty of Medicine, Udayana University and Sanglah Hospital, Bali, Indonesia; ¶¶¶National Center for HIV/AIDS, Dermatology and STDs, and University of Health Sciences, Phnom Penh, Cambodia; and ###TREAT Asia, amfAR-The Foundation for AIDS Research, Bangkok, Thailand
J. Acquir. Immune Defic. Syndr., 2015 Jul 1;69(3):e85-92.
PMID: 25850606 DOI: 10.1097/QAI.0000000000000634

Abstract

Current treatment guidelines for HIV infection recommend routine CD4 lymphocyte (CD4) count monitoring in patients with viral suppression. This may have a limited impact on influencing care as clinically meaningful CD4 decline rarely occurs during viral suppression.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.